ModelEdge

Corporate Research Intelligence

Powerful AI-driven insights from SEC Filings, Transcripts, and Market Data

Real-time Analysis

Advanced language models process corporate data instantly

Comprehensive Data

SEC filings, transcripts, insider trades, and industry insights

Market Edge

Get the competitive advantage with data-driven decisions

Latest Market Updates

Recent press releases from leading public companies

EBR•Brazilian Electric Power Co
1 day ago

Completes Mandatory Exchange of Class B1 Preferred Shares and ADSs

Merger Or Acquisition
MNSO•Miniso Group Holding Ltd
1 day ago

Reports Next Day Disclosure Returns

Other
BZ•Kanzhun Ltd
1 day ago

Announces Next Day Disclosure Return

Other
TRI•Thomson Reuters Corporation
1 day ago

Announces Voting Results for Election of Directors

Statement Of Voting Direction
ITUB•Itau Unibanco Holding SA
1 day ago

Announcement to the Market Perpetual Subordinated Financial Bills

Bonds Purchased Or Issued
USAS•Americas Gold & Silver Corp
1 day ago

Reports Foreign Private Issuer Form 6-K for June 2026

Announcement Of Date When Earnings Will Be Reported Or When It Will Be Released
PHVS•Pharvaris
1 day ago

Convening Notice for the Annual General Meeting of Shareholders to be Held on June 26, 2026

Statement Of Voting Direction
NRIX•Nurix Therapeutics Inc.
1 day ago

To Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy

Other
XERS•Xeris Biopharma Holdings Inc.
1 day ago

Announces Private Exchange Of Convertible Notes

Bonds Purchased Or Issued
TRI•Thomson Reuters Corporation
1 day ago

Announces Voting Results for Election of Directors

Statement Of Voting Direction
TRI•Thomson Reuters Corporation
1 day ago

Report of Voting Results for 2026 Annual Meeting of Shareholders

Statement Of Voting Direction
ITUB•Itau Unibanco Holding SA
1 day ago

Reports Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934

Other
NVS•Novartis AG
1 day ago

Delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint

Other
ELVN•Enliven Therapeutics Inc.
1 day ago

Announces Updated Positive Phase 1 Clinical Data and Alignment with FDA on Key Phase 3 Trial Design Components

Other
PHVS•Pharvaris
1 day ago

Announces 2026 Annual General Meeting of Shareholders

Announcement Of Date When Earnings Will Be Reported Or When It Will Be Released
PHVS•Pharvaris
1 day ago

Announces Annual General Meeting of Shareholders

Announcement Of Date When Earnings Will Be Reported Or When It Will Be Released
PHVS•Pharvaris
1 day ago

Registers for Annual General Meeting of Shareholders

Statement Of Voting Direction
PHVS•Pharvaris
1 day ago

Annual Report for the Fiscal Year Ended December 31, 2025

Other
BZ•Kanzhun Ltd
1 day ago

Announces Changes in Issued Shares and Treasury Shares

Stock Buyback
MNSO•Miniso Group Holding Ltd
1 day ago

Announces Changes in Issued Shares and Treasury Shares

Stock Buyback